Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc., as indicated in the metadata) on September 24, 2019. The filing serves as a Regulation FD disclosure to update shareholders on the company's capital structure.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative metric disclosed is the share count:
- Common Stock Outstanding: 2,638,291 shares (par value $0.01 per share) as of September 24, 2019.
Material Changes
The filing does not explicitly detail material changes in financial position compared to prior periods. It solely reports the current number of issued and outstanding shares.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural disclosure of share count.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name (Palisade Bio, Inc.) and the actual registrant (Neuralstem, Inc.).
- Confirm the trading symbol CUR on the NASDAQ Capital Market.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains none.